Search Results - Yangkui Gu
- Showing 1 - 5 results of 5
-
1
-
2
Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C... by Tianqi Zhang, Zhijun Geng, Mengxuan Zuo, Jibin Li, Jinhua Huang, Zilin Huang, Peihong Wu, Yangkui Gu
Published 2023Artigo -
3
-
4
-
5
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance by Lin Mei, Xiao-Long Zhang, Rui You, You‐Ping Liu, Hongmin Cai, Lizhi Liu, Xuefei Liu, Xiong Zou, Yu‐Long Xie, Ruhai Zou, Yi-Nuan Zhang, Rui Sun, Weiyi Feng, Haiyan Wang, Guihua Tao, Haojiang Li, Wenjie Huang, Chao Zhang, Pei-Yu Huang, Jin Wang, Qi Zhao, Qi Yang, Hong-Wan Zhang, Ting Liu, Huifeng Li, Xiaobing Jiang, Jun Tang, Yangkui Gu, Tao Yu, Zhi‐Qiang Wang, Lin Feng, Tiebang Kang, Zhixiang Zuo, Ming‐Yuan Chen
Published 2023Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cancer
Surgery
Ablation
Biology
Carcinoma
Hepatocellular carcinoma
Metastasis
Microwave ablation
Radiation therapy
Radiology
Survival rate
Adrenocortical carcinoma
Adverse effect
Apatinib
Bioinformatics
Biopsy
Brachytherapy
Cancer research
Chemotherapy
Clinical significance
Colorectal cancer
Combination therapy
Complication
FOLFOX
Gastroenterology
Liver cancer
Log-rank test
Lung cancer